Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Derisking Affinity Optimization for Macrocycles and Cyclic Peptides: High-Precision Free Energy Simulations across Five Diverse Targets.

Journal of chemical information and modeling·2026
Same author

Targeting the H/KRAS α4-β6-α5 Allosteric Lobe with Macrocyclic Peptides.

ACS medicinal chemistry letters·2026
Same author

TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells.

Life science alliance·2026
Same author

Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy <i>via</i> C-Terminal Peptide Engineering and Allosteric Site Targeting.

Journal of medicinal chemistry·2026
Same author

Unique Interactions of Novel Rufomycin "Click Chemistry" Analogs with <i>Mtb</i> ClpC1 and Implications.

Journal of medicinal chemistry·2025
Same author

Gαq-Stimulated Gene Expression Is Insensitive to Bromo Extra Terminal Domain Inhibitors in HEK 293 Cells.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Apr 14, 2026

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells
09:21

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells

Published on: November 7, 2025

856

Quantifying biased signaling in GPCRs using BRET-based biosensors.

Yoon Namkung1, Olivier Radresa1, Sylvain Armando1

  • 1Department of Medicine, McGill University Health Center Research Institute, McGill University, Montréal, Canada.

Methods (San Diego, Calif.)
|April 19, 2015
PubMed
Summary

Researchers developed a method to measure biased signaling in G protein-coupled receptors (GPCRs). This approach helps classify drugs for improved therapeutic efficacy by analyzing their signaling pathways.

Keywords:
Angiotensin II type 1 receptorBRETBiased signalingG proteinsOperational modelβ-Arrestin

More Related Videos

Monitoring GPCR-&#946;-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

7.5K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

835

Related Experiment Videos

Last Updated: Apr 14, 2026

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells
09:21

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells

Published on: November 7, 2025

856
Monitoring GPCR-&#946;-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

7.5K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

835

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • G protein-coupled receptors (GPCRs) play crucial roles in cellular signaling.
  • Functional selectivity, or biased signaling, allows ligands to preferentially activate specific downstream pathways.
  • Understanding biased signaling is key to developing more effective and targeted therapeutics.

Purpose of the Study:

  • To establish a robust experimental protocol for assessing functional selectivity between G protein- and β-arrestin-dependent signaling pathways.
  • To quantify ligand bias for specific GPCRs using a defined experimental system.
  • To provide a framework applicable to various GPCRs and their signaling effectors.

Main Methods:

  • Utilized HEK 293 cells expressing the angiotensin II type 1 receptor (AT1R).
  • Employed Bioluminescence Resonance Energy Transfer (BRET) sensors to monitor Gαq and β-arrestin recruitment.
  • Applied the operational model of pharmacological agonism to quantify ligand-induced bias.

Main Results:

  • Successfully demonstrated a method to differentiate between Gαq and β-arrestin signaling pathways for AT1R ligands.
  • Quantified the signaling bias of specific ligands towards either Gαq or β-arrestin.
  • Validated the protocol's utility in characterizing GPCR functional selectivity.

Conclusions:

  • The described protocol provides a reliable method for pharmacologically characterizing GPCR functional selectivity.
  • This approach enables the classification of ligands based on their biased signaling profiles.
  • The methodology is adaptable for diverse GPCRs, facilitating drug discovery and development for improved therapies.